Company intelligence / Profile preview

Hasan-Dermapharm Joint Venture Co., Ltd.

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Hasan-Dermapharm, established in 2004, is one of the most developed pharmaceutical companies in Vietnam, using about 80 active ingredients to manufacture a wide range of products for domestic and export markets.[2] No clinical trial results are reported.

Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

nifedipine

Commercial

Indications: Cardiovascular disease

Partnerships

Orchid Pharma Ltd. (India)Sinobright Pharma Co. Ltd. (China)

Beyond the preview

Go deeper on Hasan-Dermapharm Joint Venture Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hasan-Dermapharm Joint Venture Co., Ltd..

Explore the full profile